Acute hyperosmolar hyperglycaemic state in cystic fibrosis-related diabetes caused by glucocorticoid and itraconazole interaction
- 11 September 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 20 (2), 330-332
- https://doi.org/10.1016/j.jcf.2020.08.018
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar statePediatric Diabetes, 2018
- Does β-Cell Autoimmunity Play a Role in Cystic Fibrosis–Related Diabetes? Analysis Based on the German/Austrian Diabetes Patienten Verlaufsdokumentation RegistryDiabetes Care, 2016
- An unusual cause of growth failure in cystic fibrosis: A salutary reminder of the interaction between glucocorticoids and cytochrome P450 inhibiting medicationJournal of Cystic Fibrosis, 2015
- Itraconazole and inhaled fluticasone causing hypothalamic–pituitary–adrenal axis suppression in adults with cystic fibrosisJournal of Cystic Fibrosis, 2013
- No Relation Between Cystic Fibrosis–Related Diabetes and Type 1 Diabetes AutoimmunityDiabetes Care, 2012
- Cushing's Syndrome Due to Interaction Between Inhaled Corticosteroids and ItraconazoleAnnals of Pharmacotherapy, 2004
- The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisoloneEuropean Journal of Clinical Pharmacology, 2000
- Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionateThe Lancet, 1996